Skip to main content Skip to main navigation menu Skip to site footer

Kadar serotonin serum yang rendah merupakan factor resiko terjadinya eritema nodusum leprosum

Abstract

Background: Type 2 reactions or erythema nodosum leprosum is one of the serious complications of morbus hansen that occurs in patients with poor cellular immunity to Mycobacterium leprae. There are several factors considered to cause ENL such as lepromatous leprosy, patients who have received antileprosy treatment, bacterial index of more than +4, other infections such as Streptococcus, age less than 40 years, pregnancy, trauma or surgery, physical and mental stress. Physical and mental stress. Serotonin is a neurotransmitter that can decrease in a state of mental stress. This study aims to prove that low serum serotonin levels are a risk factor for erythema nodosum leprosum in morbus hansen patients.

Method: This study was a case control study conducted at the Dermatovenereology Polyclinic of Sanglah Hospital Denpasar which involved 25 subjects of erythema nodosum leprosum and 25 subjects not erythema nodosum leprosum that fulfilled the inclusion and exclusion criteria, performed venous blood sampling as material examination serotonin serum level with enzyme-linked immunosorbent assay (ELISA) technique. The collected data was analyzed using SPSS version 21.0 with Pearson Chi Square test to obtain Odds Ratio.

Results: This study showed that serum serotonin levels in the case group were significantly lower than the control group (p<0.05). Odds ratio for serum serotonin was 12.67 (95% CI=3.308-48.504; p<0.001).

Conclusion: In this study it can be concluded that low serum serotonin levels are risk factors for erythema nodosum leprosum.


Latar Belakang: Reaksi tipe 2 atau eritema nodosum leprosum adalah salah satu komplikasi morbus hansen yang serius yang terjadi pada penderita dengan imunitas seluler yang buruk terhadap Mycobacterium leprae. Terdapat beberapa faktor yang dianggap dapat mencetuskan ENL antara lain kusta lepromatosa, pasien yang telah mendapatkan pengobatan antikusta, indeks bakteri lebih dari +4, infeksi lain seperti Streptokokus, usia kurang dari 40 tahun, kehamilan, trauma atau pembedahan, stres fisik dan mental. Serotonin merupakan suatu neurotransmiter yang dapat menurun pada keadaan stres mental. Penelitian ini bertujuan untuk membuktikan bahwa bahwa kadar serotonin serum yang rendah merupakan faktor risiko terjadinya eritema nodosum leprosum pada pasien morbus hansen.

Metode: Penelitian ini merupakan penelitian case control study yang dilakukan di Poliklinik Kulit dan Kelamin RSUP Sanglah Denpasar yang melibatkan 25 subyek eritema nodosum leprosum dan 25 subyek bukan eritema nodosum leprosum yang memenuhi kriteria inklusi dan eksklusi, kemudian dilakukan pengambilan darah vena sebagai pemeriksaan kadar serotonin serum menggunakan teknik enzyme- linked immunosorbent assay (ELISA). Data yang terkumpul dianalisis menggunakan SPSS versi 21.0 dengan uji Pearson Chi Square untuk mendapatkan Odds Ratio.

Hasil: Pada penelitian ini didapatkan bahwa kadar serotonin serum pada kelompok kasus lebih rendah secara bermakna dibandingkan kelompok kontrol (p<0,05). Odds ratio untuk serotonin serum adalah 12,67 (95% CI=3,308-48,504, p<0,001).

Kesimpulan: Pada penelitian dapat disimpulkan bahwa kadar serotonin serum yang rendah merupakan faktor risiko terjadinya eritema nodosum leprosum.


References

  1. Chaptini C, Marshman G. Leprosy: A Review on elimination, reducing the disease Burden, and future research. Lepr Rev. 2015;86:307-315.
  2. Noriega LF, Noriega AF, Vieira ML, Chiacchio ND, Pereira GA. Leprosy: ancient disease remains a public health problem nowadays. An Bras Dermatol. 2016;91(4):547-548.
  3. World Health Organization. Global Leprosy Update, 2015: Time for action, accountability and inclusion. Weekly epidemiological record. 2016;35:405-420.
  4. Raffe SF, Thapa M, Khadge S, Tamang K, Hagge D, Lockwood DN. Diagnosis and Treatment of Leprosy Reactions in Integrated Services-The Patients' Perspective in Nepal. PLoS Negl Trop Dis. 2013;7(3):e2089.
  5. Pulido-PA, Mendoza-Cembranos MD, Avilés-Izquierdo JA., Suárez-FR. Erythema Nodosum Leprosum and Reversal Reaction in 2 Cases of Imported Leprosy. Actas Dermosifiliogr. 2013;104:915-919.
  6. Sreenivasan P, Misrat RS, Wilfred D, Nath I. Lepromatous leprosy patients show T helper 1-like cytokine profile with differential expression of interleukin-10 during type 1 and 2 reactions. Immunology. 1998;95:529-536.
  7. Goulart LR, Goulart IMB. Leprosy Pathogenetic Background: A Review and Lessons From Other Mycobacterial Disease. Arch Dermatol Res. 2008;2(2):1-15.
  8. Kar HK, Kumar B. IAL Texbook of Leprosy. India: Jaypee. 2010. p.152-166.
  9. Roman I, Constantin A, Marina M, Orasan R. The role of hormones in the pathogenesis of psoriasis vulgaris. Clujul medical. 2016;89(1):11-18.
  10. Thorslund K, Nour H, Nordlind K. The serotonin transporter protein is expressed in psoriasis, where it may play a role in regulating apoptosis. Arch Dermatol Res. 2010;301(6):449-457.
  11. Kaur H, Brakel. Dehabilitation of leprosy-affected people--a study on leprosy-affected beggars. Lepr Rev. 2002;73(4):346–355.
  12. Pieter AMS. The Occurrence of Reactions and Impairment in Leprosy: Experience in the Leprosy Control Program of Three Provinces in Northeastern Thailand 1978 –1995. International Journal of Leprosy. 1998;66(2):159-167.
  13. Kubera M, Maes M, Kenis G, Kim YK, Lason W. Effect of serotonin and serotonergic agonist and antagonist on the production of tumor necrosis factor alpha and interleukin-6. Psychiatry Res. 2005;134(3):251-258.
  14. Eduardo S, et al. Serotonin inhibition of tumor necrosis factor alpha synthesis by human monocytes. Life sciences. 1991;48(26):2557-2562.
  15. Moraes MO, Sarno EN, Teles RMB, Almeida AS, Saraiva BCC, Nery JA, Sampaio EP. Anti-Inflammatory Drugs Block Cytokine mRNA Accumulation in the Skin and Improve the Clinical Condition of Reactional Leprosy Patients. The Journal Of Investigative Dermatology. 2000;115:935-941.
  16. Goulart MB, Souza DOB, Marquez CR, Pimenta VL, Goncalves MA, Goulart LR. Risk and Protective Factors for Leprosy Development Determined by Epidemiological Surveillance of Household Contacts. Clinical and Vaccine Immunnology. 2008;15(1):101-05.
  17. Solomon S, Kurian N, Ramadas P, Simon SRPS. Incidence of Nerve Damage in Leprosy Patients Treted With MDT. International Journal of Leprosy. 1998; 66(4):451-455.

How to Cite

Thungady, E., Mas Rusyati, L. M., & Praharsini, I. (2020). Kadar serotonin serum yang rendah merupakan factor resiko terjadinya eritema nodusum leprosum. Medicina, 51(1). https://doi.org/10.15562/medicina.v51i1.388

HTML
134

Total
220

Share

Search Panel